Poland· PL-100485854
Dagetia
A dapagliflozin product containing dapagliflozinum, registered in Poland by Pharmapath S.A.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dapagliflozin is registered in 16 of 19 countries.
Countries holding a registration under ATC A10BK01 (dapagliflozin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Dapagliflozin · ATC A10BK01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dapagliflozin costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.33 in United States to $4.38 in Switzerland — a ×13 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Dapagliflozin · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.38
- IT Italy$3.42
- US United States$0.33 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Dapagliflozinum
- Manufacturer
- Pharmapath S.A.
- Country
- Poland (PL)
- ATC code
- A10BK01
- ATC class
- Dapagliflozin
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 17
- gtin05909991573195
- gtin05909991573201
- gtin05909991573218
- gtin05909991573225
- gtin05909991573232
- gtin05909991573249
- gtin05909991573256
- gtin05909991573300
- gtin05909991573263
- gtin05909991573270
- gtin05909991573287
- gtin05909991573294
- gtin05909991573317
- gtin05909991573324
- gtin05909991573331
- gtin05909991573348
- gtin05909991573355
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
426 interactions on record for dapagliflozin.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dapagliflozin · interactions on record
426 records
- 1 severe
- 378 moderate
- 47 minor
Most severe, free to view
- SucralfateA02BX02moderate
- PapaverineA03AD01moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dapagliflozin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDAPAGLIFLOZIN AVIANTAAvianta Pharma EU Limited, Dublin
- United StatesDapagliflozinAscend Laboratories, LLC
- SpainDAFORBIS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGViatris Limited
- NetherlandsDapagliflozine Accord 5 mg filmomhulde tablettenAccord Healthcare B.V.
- SwedenDaforbis 5 mg Filmdragerad tablettViatris Limited
- SwitzerlandDapagliflozin Devatis 5 mg, FilmtablettenDevatis AG
- IcelandDapagliflozin KrkaKrka, d.d., Novo mesto
- IrelandDapagliflozin MSN 5 mg film-coated tabletsMSN Labs Europe Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dapagliflozin +pharma, Dapagliflozin Devatis
- Belgium · Dapagliflozin Ab, Dapagliflozin Eg
- Bulgaria · Dapagliflozin Sandoz, Dapagliflozin Tchaikapharma
- Cyprus · Daforbis, Dapagliflozin Farmoz
- Czechia · Dagetia, Dagrafors
- Germany · Daglin, Dapagliflozin 123-Acurae Pharma
- Denmark · Dapagliflozin, Dapagliflozin "sandoz"
- Estonia · Dagrafors, Dapagliflozin Alembic
- Spain · Daforbis, Dapagliflozina Aurovitas
- Finland · Dapagliflozin Devatis, Dapagliflozin Krka
- France · Dapagliflozine Arrow, Dapagliflozine Biogaran
- United Kingdom (Northern Ireland) · Daforbis, Dapagliflozin
- Greece · Brolertix, Daforbis
- Croatia · Daforbis, Dagrafors
- Hungary · Dagrafors, Dapagliflozin Sandoz
- Ireland · Dapagliflozin Clonmel, Dapagliflozin Krka
- Iceland · Dapagliflozin Krka, Dapagliflozin Krka D.D.
- Italy · Dapagliflozin Aurobindo, Dapagliflozin Doc
- Liechtenstein · Dapagliflozin Viatris, Edistride
- Lithuania · Dagrafors, Dapagliflozin Accord
- Luxembourg · Dapagliflozin Eg
- Latvia · Daglin, Dagrafors
- Malta · Dapagliflozin Ascend, Dapagliflozin Aurobindo
- Netherlands · Dapagliflozin Alembic, Dapagliflozin Amarox
- Norway · Dapagliflozin Alembic, Dapagliflozin Devatis
- Portugal · Dalzior, Dapagliflozin Ipca
- Romania · Daforbis, Dagetia
- Sweden · Daforbis, Dapagliflozin Adalvo
- Slovenia · Dagrafors, Dapagliflozin Hcs
- Slovakia · Dagetia, Dagrafors
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6be4192-473e-45b2-baf0-230676bc1312 GET /v1/drugs/d6be4192-473e-45b2-baf0-230676bc1312?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909991573195 ¦ Rp ¦ 161803\n10 tabl. w blistrze\n05909991573201 ¦ Rp ¦ 161804\n28 tabl. w blistrze\n05909991573218 ¦ Rp ¦ 161805\n30 tabl. w blistrze\n05909991573225 ¦ Rp ¦ 161806\n60 tabl. w blistrze\n05909991573232 ¦ Rp ¦ 161807\n90 tabl. w blistrze\n05909991573249 ¦ Rp ¦ 161808\n98 tabl. w blistrze\n05909991573256 ¦ Rp ¦ 161809\n10 tabl. w blistrze perforowanym\n05909991573300 ¦ Rp ¦ 161810\n28 tabl. w blistrze perforowanym\n05909991573263 ¦ Rp ¦ 161811\n30 tabl. w blistrze perforowanym\n05909991573270 ¦ Rp ¦ 161812\n50 tabl. w blistrze perforowanym\n05909991573287 ¦ Rp ¦ 161813\n90 tabl. w blistrze perforowanym\n05909991573294 ¦ Rp ¦ 161814\n98 tabl. w blistrze perforowanym\n05909991573317 ¦ Rp ¦ 161815\n100 tabl. w blistrze perforowanym\n05909991573324 ¦ Rp ¦ 161816\n14 tabl. w blistrze kalendarzowym\n05909991573331 ¦ Rp ¦ 161817\n28 tabl. w blistrze kalendarzowym\n05909991573348 ¦ Rp ¦ 161818\n56 tabl. w blistrze kalendarzowym\n05909991573355 ¦ Rp ¦ 161819\n98 tabl. w blistrze kalendarzowym",
"substance": "Dapagliflozinum 5 mg",
"common_name": "Dapagliflozinum",
"pl_product_id": "100485854",
"pozwolenie_nr": "29029",
"auth_procedure": "DCP",
"authorisation_validity": "2025-12-03"
}See everything about dapagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.